Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype
Open Access
- 1 February 2010
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 120 (2), 636-644
- https://doi.org/10.1172/jci40724
Abstract
Intratumor genetic heterogeneity is a key mechanism underlying tumor progression and therapeutic resistance. The prevailing model for explaining intratumor diversity, the clonal evolution model, has recently been challenged by proponents of the cancer stem cell hypothesis. To investigate this issue, we performed combined analyses of markers associated with cellular differentiation states and genotypic alterations in human breast carcinomas and evaluated diversity with ecological and evolutionary methods. Our analyses showed a high degree of genetic heterogeneity both within and between distinct tumor cell populations that were defined based on markers of cellular phenotypes including stem cell–like characteristics. In several tumors, stem cell–like and more-differentiated cancer cell populations were genetically distinct, leading us to question the validity of a simple differentiation hierarchy–based cancer stem cell model. The degree of diversity correlated with clinically relevant breast tumor subtypes and in some tumors was markedly different between the in situ and invasive cell populations. We also found that diversity measures were associated with clinical variables. Our findings highlight the importance of genetic diversity in intratumor heterogeneity and the value of analyzing tumors as distinct populations of cancer cells to more effectively plan treatments.Keywords
This publication has 35 references indexed in Scilit:
- Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast CancerClinical Cancer Research, 2010
- Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosisNature, 2009
- Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic LeukemiaScience, 2008
- Cell type-specific DNA methylation patterns in the human breastProceedings of the National Academy of Sciences of the United States of America, 2008
- Regulation of In Situ to Invasive Breast Carcinoma TransitionCancer Cell, 2008
- MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 SignalingScience, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJama-Journal Of The American Medical Association, 2006
- Genetic heterogeneity of single disseminated tumour cells in minimal residual cancerThe Lancet, 2002
- On optimal and data-based histogramsBiometrika, 1979
- Algorithm AS 136: A K-Means Clustering AlgorithmJournal of the Royal Statistical Society Series C: Applied Statistics, 1979